Evidence map›Paper›PMID 41095346›Full record

ArticleMaterials (Basel, Switzerland)2025

Water-Soaking Pretreatment for Enhanced Performance and Heavy Metal Immobilization in Alkali-Activated Pyrolysis MSWIFA Materials.

Shengyu Zhong, Liang Shen, Wanlan Xu, Yi Fang, Yunfeng Pan

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shengyu ZhongSchool of Civil Engineering and Architecture, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Liang ShenHangzhou Huihong Environmental Technology Co., Ltd., Hangzhou 310058, China.
Wanlan XuSchool of Civil Engineering and Architecture, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Yi FangCollege of Civil and Transportation Engineering, Hohai University, Nanjing 210098, China.ORCID 0000-0002-2047-9931
Yunfeng PanSchool of Civil Engineering and Architecture, Zhejiang Sci-Tech University, Hangzhou 310018, China.ORCID 0000-0002-5813-9801

Funding

Key Research and Development Program of Hangzhou City Grants No.2024SZD1B23
6 · The paper itself

Abstract

This study demonstrates that synergistic pyrolysis and water-soaking pretreatment transforms municipal solid waste incineration fly ash (MSWI FA) into high-performance alkali-activated materials when combined with ground granulated blast furnace slag (GGBS). Pyrolysis reduced chlorine content by 94.3% and increased reactive components by 44.4%, thereby shifting hydration products from Friedel's salt to ettringite (AFt). Subsequent water-soaking eliminated expansion-causing elemental aluminum, liberating activators for enhanced reaction completeness (29% higher cumulative heat release) and enabling a denser matrix with 71.5% harmless pores (<20 nm). The dual-treated FA (T-PFA) achieved exceptional mechanical performance-295.6% higher 56-day compressive strength versus untreated FA at a 1:1 ratio-while reducing porosity by 29.1% relative to pyrolyzed-only FA. Despite 22-38% increased total heavy metal content post-pyrolysis, matrix densification and enhanced C-A-S-H/AFt formation reduced Cr/Cd/Cu/Pb leaching by 11.3-66.7% through strengthened physical encapsulation and chemisorption, with all leachates meeting stringent HJ 1134-2020 thresholds. This integrated approach provides an efficient, environmentally compliant pathway for MSWI FA valorization in low-carbon construction materials.

Indexed as

alkali-activated materialscompressive strengthheavy metals solidificationMSWIFApyrolysis fly ash

Identifiers

PMID41095346
PMCPMC12525636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.